NCT03994289

Brief Summary

Exercise has been the cornerstone of diabetes management. However, many diabetic patients have ADL disabilities and experience substantial difficulty in performing usual exercises, such as brisk walking and upright cycling. There is an urgent need to provide alternative exercise modalities for diabetic patients with ADL disabilities. In this study, investigators will investigate the effects on the glucose of three exercise modalities, including motor-assisted cycling (i.e., cycling on a motor-driven bike) and functional electrical stimulation (FES) cycling, during which the investigators will use electrical current to facilitate cycling movements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2019

Completed
Last Updated

November 15, 2019

Status Verified

November 1, 2019

Enrollment Period

9 months

First QC Date

June 19, 2019

Last Update Submit

November 14, 2019

Conditions

Keywords

exerciseFES

Outcome Measures

Primary Outcomes (1)

  • Postprandial glucose AUC

    The glucose will be measured using CGM during the 2-hour postprandial period.

Study Arms (3)

Control

NO INTERVENTION

Participants remain seated for 2 hours after the intake of a standardized breakfast.

Motor-assisted cycling

EXPERIMENTAL

Participants will perform 3 bouts of motor-assisted cycling, each bout lasting 10 minutes, after the intake of a standardized breakfast.

Behavioral: Motor-assisted cycling

FES cycling

EXPERIMENTAL

Participants will perform 3 bouts of FES cycling, each bout lasting 10 minutes, after the intake of a standardized breakfast.

Behavioral: FES cycling

Interventions

Participants will perform the motor-assisted cycling exercise using a physical therapy bike (RECK; Betzenweiler, Germany). Participants will perform 3×10-min bouts of motor-assisted cycling at the highest tolerable cadence. Before each bout, participants will perform 1-2 minutes of motor-assisted cycling at 5-10 rpm as a warm-up.

Motor-assisted cycling
FES cyclingBEHAVIORAL

The testing procedures will be identical to that in the motor-assisted cycling visit except for the exercise type. Participants will wear FES cuffs on the upper and lower legs, bilaterally. . The FES cycling will be performed on the motor-assisted bike using the wearable FES equipment. The purpose of motor-assisted cycling is to provide constant cadence. The Bioness L300 Plus system (Bioness, Valencia, CA) will be worn on the upper and lower legs to stimulates the quadriceps and dorsiflexors muscles during the motor-driven cycling exercise. An embedded gyroscope of the cuff can detect the motion of the lower leg so that the electrical stimulations will be generated at appropriate timing to activate leg muscles during the cycling exercise.

FES cycling

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 60 years.
  • Physician-diagnosed type 2 diabetes.
  • ADL disability (self-reported).

You may not qualify if:

  • Fasting glucose ≥ 250 mg/dL.
  • Symptomatic hypoglycemic events in the past three months.
  • Insulin injection or infusion
  • Systolic blood pressure ≥ 160 mmHg OR Diastolic blood pressure ≥ 100 mmHg
  • Diagnosis of NYHA class I-IV heart failure
  • Myocardial infarction in the past 6 months
  • Recent or current angina, shortness of breath, or other symptoms suggestive of heart failure
  • Diagnosed Cancer
  • Unable to consent due to impaired cognitive function
  • Bone fracture, joint dislocation, or joint stiffness
  • Local skin disorders at the FES cuff area or CGM sensor area
  • Implantable electronic or metallic devices, such as cardioverter defibrillator and pacemaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brookdale Senior Living Central Chandler

Chandler, Arizona, 85224, United States

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 19, 2019

First Posted

June 21, 2019

Study Start

February 20, 2019

Primary Completion

November 15, 2019

Study Completion

November 15, 2019

Last Updated

November 15, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations